Drug shows promise in 1st COVID
study of largely minority patients
|
|
A drug company
said Friday that a medicine it sells to tamp down inflammation has helped
prevent the need for breathing machines in hospitalized COVID-19 patients in
the first large study that primarily enrolled Hispanics and Blacks. |
No comments:
Post a Comment